[1]
Z. Gong, S. Han, C. Zhang, H. Zhao, J. Xu, and X. Sun, “Value of serum miR-21, HE4 and CA125 in surveillance for postoperative recurrent or metastatic ovarian cancer”, Pak J Med Sci, vol. 38, no. 4, Mar. 2022.